跳至主要内容
临床试验/NL-OMON44684
NL-OMON44684已完成不适用

Antibodies Causing Epilepsy Syndromes - ACES Study

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 1,380 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,380

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age of 18 and older.
  • - Status epilepticus or new onset seizures with signs of limbic encephalitis (clinical picture, MRI (FLAIR abnormalities), EEG abnormalities or CSF findings (CSF pleocytosis, increased IgG index, oligoclonal bands)
  • - Patients with acquired chronic focal epilepsy with an unknown cause.
  • - A subgroup of these patients, with chronic focal epilepsy, undergoing epilepsy surgery (without a known underlying cause of their epilepsy or possible (post) encephalitis changes, like mesiotemporal sclerosis and hippocampal sclerosis). These are patients with a pharmacoresistent epilepsy, not responding to first and second-line anti-epileptic drugs.

排除标准

  • Patients < 18 years.
  • Epilepsy with known cause.

研究者

相似试验